Diabetic muscle infarction after simultaneous pancreas-kidney transplant

Spiros Delis1, Gaetano Ciancio, Javier Casillas

  • 1Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA.

Insights

Diabetic muscle infarction (DMI) is a rare complication in patients with type 1 diabetes. This study highlights DMI occurring post-kidney-pancreas transplant in patients with end-stage renal disease and diabetes, suggesting underlying diabetic complications contribute.

Area of Science:

  • Endocrinology
  • Nephrology
  • Vascular Medicine

Background:

  • Diabetic muscle infarction (DMI) is a rare complication typically seen in patients with long-standing type 1 insulin-dependent diabetes mellitus (IDDM).
  • End-stage renal disease (ESRD) often coexists with long-term diabetic complications.

Observation:

  • This case series describes four patients with IDDM and ESRD who developed DMI approximately 5 months after simultaneous kidney-pancreas transplantation (SPK).
  • These patients exhibited pre-existing diabetic complications like retinopathy, neuropathy, microangiopathy, and hypercoagulability, known risk factors for DMI.

Findings:

  • Despite achieving normoglycemia post-transplantation, DMI occurred, indicating that pre-existing tissue damage from labile glycemic control and hypertension plays a role.
  • The use of calcineurin inhibitors and steroids in immunosuppressive regimens may exacerbate DMI risk due to their pro-coagulant effects.

Implications:

  • DMI can occur even after successful SPK in patients with a history of long-term diabetes and its complications.
  • Understanding these contributing factors is crucial for managing and potentially preventing DMI in this vulnerable patient population.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...